Full text is available at the source.
Cardiovascular effects of tirzepatide
Tirzepatide's effects on heart and blood vessel health
AI simplified
Abstract
Tirzepatide demonstrates unprecedented efficacy for glycaemic control, body weight reduction, and improvements in blood pressure and lipid profile compared with placebo and GLP-1 receptor agonists.
- Tirzepatide is a dual agonist that targets receptors for GLP-1 and GIP, potentially offering new treatment options for type 2 diabetes (T2D) and obesity.
- Clinical trials have shown that tirzepatide meets regulatory requirements for cardiovascular safety in high-risk patients.
- The potential cardiovascular benefits of tirzepatide remain uncertain, particularly regarding the role of GIP receptor activation in cardiovascular risk.
- Ongoing large-scale trials will help clarify the positioning of tirzepatide in the treatment of patients with established cardiovascular disease or those at high risk.
AI simplified